This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cell | 1397 |
- | hsct | 1132 |
hematopoietic | stem | 1006 |
- | transplant | 863 |
- | cells | 521 |
median | time | 485 |
high | risk | 428 |
- | risk | 424 |
immune | response | 338 |
viral | infections | 333 |
- | time | 245 |
- | t | 242 |
renal | transplant | 230 |
hematopoietic | cell | 226 |
specific | t | 209 |
immune | responses | 186 |
- | transplantation | 180 |
acute | graft | 170 |
viral | infection | 156 |
- | cmv | 151 |
- | year | 142 |
first | year | 126 |
renal | transplantation | 126 |
chronic | graft | 105 |
respiratory | viruses | 96 |
higher | risk | 91 |
- | infection | 89 |
primary | infection | 79 |
first | time | 77 |
renal | disease | 70 |
- | group | 67 |
human | t | 62 |
- | recipient | 61 |
severe | disease | 59 |
- | donor | 58 |
- | treatment | 57 |
low | risk | 56 |
respiratory | virus | 54 |
significant | risk | 52 |
primary | graft | 52 |
immune | cells | 51 |
median | day | 51 |
overall | response | 50 |
respiratory | infections | 50 |
clinical | response | 49 |
first | month | 49 |
immune | cell | 47 |
positive | cells | 46 |
severe | cases | 45 |
- | virus | 44 |
different | time | 44 |
severe | infections | 44 |
- | disease | 42 |
hematopoietic | cells | 41 |
positive | patients | 41 |
viral | diseases | 36 |
other | patients | 32 |
clinical | studies | 32 |
first | day | 31 |
severe | infection | 31 |
- | patient | 31 |
other | infections | 30 |
other | studies | 30 |
other | viruses | 30 |
peripheral | stem | 30 |
such | patients | 30 |
primary | disease | 29 |
clinical | disease | 29 |
other | groups | 29 |
chronic | infection | 28 |
negative | patients | 28 |
- | day | 27 |
lower | risk | 27 |
respiratory | infection | 27 |
- | patients | 25 |
respiratory | disease | 24 |
- | response | 24 |
highest | risk | 24 |
peripheral | t | 23 |
other | patient | 23 |
other | diseases | 22 |
clinical | study | 21 |
human | disease | 21 |
median | days | 21 |
specific | treatment | 21 |
longer | time | 20 |
severe | graft | 20 |
- | month | 19 |
early | treatment | 19 |
first | patient | 19 |
positive | recipients | 19 |
viral | disease | 19 |
- | therapy | 18 |
primary | cmv | 18 |
specific | therapy | 17 |
positive | donor | 17 |
hematopoietic | transplantation | 17 |
first | transplant | 17 |
first | case | 16 |
long | time | 16 |
such | infections | 15 |
- | days | 15 |
acute | infection | 15 |
human | cells | 15 |
positive | cmv | 15 |
positive | results | 15 |
severe | t | 15 |
early | disease | 14 |
positive | donors | 14 |
primary | cells | 13 |
other | risk | 13 |
negative | results | 13 |
renal | transplants | 13 |
significant | cmv | 13 |
significant | disease | 13 |
negative | t | 13 |
first | study | 13 |
median | patient | 13 |
different | groups | 13 |
clinical | risk | 13 |
clinical | results | 13 |
- | transplanted | 13 |
low | t | 13 |
different | cell | 12 |
severe | cmv | 12 |
primary | treatment | 12 |
human | infection | 12 |
chronic | disease | 12 |
- | recipients | 12 |
- | graft | 12 |
early | hsct | 11 |
first | results | 11 |
other | therapies | 11 |
higher | response | 10 |
specific | responses | 10 |
primary | therapy | 10 |
primary | t | 10 |
negative | group | 10 |
- | infections | 10 |
first | hsct | 10 |
early | cmv | 10 |
different | treatment | 10 |
common | infections | 10 |
- | years | 10 |
other | day | 9 |
viral | therapy | 9 |
specific | cell | 9 |
significant | infection | 9 |
renal | graft | 9 |
other | treatment | 9 |
other | cell | 9 |
negative | cmv | 9 |
median | cmv | 9 |
high | response | 9 |
different | t | 9 |
clinical | case | 9 |
- | study | 9 |
- | p | 9 |
first | group | 8 |
such | cases | 8 |
other | t | 8 |
other | cells | 8 |
median | cell | 8 |
human | cases | 8 |
high | t | 8 |
early | transplant | 8 |
early | time | 8 |
early | t | 8 |
different | donors | 8 |
different | donor | 8 |
acute | therapy | 8 |
human | cmv | 7 |
such | cells | 7 |
specific | cells | 7 |
respiratory | diseases | 7 |
positive | cases | 7 |
other | transplant | 7 |
other | group | 7 |
other | donors | 7 |
human | diseases | 7 |
specific | group | 7 |
higher | cell | 7 |
first | months | 7 |
early | graft | 7 |
common | viruses | 7 |
clinical | responses | 7 |
clinical | infection | 7 |
- | groups | 7 |
- | responses | 7 |
high | treatment | 7 |
positive | infections | 6 |
other | treatments | 6 |
overall | graft | 6 |
positive | grafts | 6 |
such | diseases | 6 |
significant | infections | 6 |
significant | response | 6 |
specific | diseases | 6 |
median | disease | 6 |
negative | recipients | 6 |
other | disease | 6 |
immune | diseases | 6 |
early | group | 6 |
high | disease | 6 |
- | stem | 6 |
acute | disease | 6 |
different | times | 6 |
different | diseases | 6 |
early | infection | 6 |
early | studies | 6 |
first | days | 6 |
first | years | 6 |
primary | diseases | 5 |
median | times | 5 |
other | donor | 5 |
positive | disease | 5 |
positive | patient | 5 |
positive | t | 5 |
viral | treatment | 5 |
renal | cell | 5 |
specific | disease | 5 |
specific | risk | 5 |
specific | virus | 5 |
immune | therapy | 5 |
median | donor | 5 |
high | transplant | 5 |
immune | disease | 5 |
early | therapy | 5 |
clinical | cases | 5 |
different | studies | 5 |
different | transplant | 5 |
different | viruses | 5 |
human | studies | 5 |
first | cmv | 5 |
acute | infections | 5 |
human | donor | 5 |
human | infections | 5 |
high | group | 5 |
positive | groups | 4 |
median | transplant | 4 |
median | treatment | 4 |
negative | cells | 4 |
negative | donor | 4 |
negative | donors | 4 |
negative | result | 4 |
non | transplant | 4 |
other | cases | 4 |
other | study | 4 |
primary | infections | 4 |
positive | result | 4 |
primary | study | 4 |
significant | t | 4 |
significant | transplant | 4 |
median | recipient | 4 |
specific | response | 4 |
specific | therapies | 4 |
such | results | 4 |
viral | response | 4 |
specific | donor | 4 |
lowest | risk | 4 |
median | % | 4 |
first | infection | 4 |
- | grafting | 4 |
- | times | 4 |
- | transplants | 4 |
- | viruses | 4 |
chronic | diseases | 4 |
low | transplant | 4 |
common | infection | 4 |
different | risk | 4 |
early | results | 4 |
common | diseases | 4 |
hematopoietic | transplant | 4 |
high | cmv | 4 |
high | donor | 4 |
high | groups | 4 |
higher | cmv | 4 |
human | patients | 4 |
low | cells | 4 |
low | disease | 4 |
hematopoietic | transplants | 4 |
other | case | 3 |
overall | responses | 3 |
overall | p | 3 |
overall | disease | 3 |
negative | infections | 3 |
non | t | 3 |
negative | response | 3 |
overall | risk | 3 |
overall | results | 3 |
negative | cell | 3 |
overall | study | 3 |
positive | group | 3 |
positive | response | 3 |
positive | stem | 3 |
renal | diseases | 3 |
renal | recipients | 3 |
specific | case | 3 |
specific | infections | 3 |
specific | transplant | 3 |
such | infection | 3 |
negative | grafts | 3 |
median | patients | 3 |
median | year | 3 |
early | transplantation | 3 |
median | stem | 3 |
acute | response | 3 |
chronic | infections | 3 |
clinical | cmv | 3 |
common | disease | 3 |
common | group | 3 |
different | patients | 3 |
earlier | studies | 3 |
earlier | treatment | 3 |
- | donors | 3 |
first | therapy | 3 |
low | response | 3 |
high | case | 3 |
lower | t | 3 |
lower | disease | 3 |
median | response | 3 |
low | group | 3 |
low | cell | 3 |
high | infection | 3 |
primary | donor | 2 |
other | graft | 2 |
primary | cell | 2 |
positive | cell | 2 |
peripheral | cells | 2 |
overall | transplant | 2 |
overall | time | 2 |
overall | result | 2 |
other | therapy | 2 |
longer | treatment | 2 |
median | group | 2 |
lower | p | 2 |
low | treatment | 2 |
immune | therapies | 2 |
immune | graft | 2 |
human | virus | 2 |
human | study | 2 |
renal | cells | 2 |
primary | transplantation | 2 |
specific | cmv | 2 |
renal | grafts | 2 |
specific | patient | 2 |
viral | t | 2 |
viral | studies | 2 |
such | therapy | 2 |
such | studies | 2 |
such | response | 2 |
specific | treatments | 2 |
specific | studies | 2 |
human | cell | 2 |
renal | infections | 2 |
significant | treatment | 2 |
significant | responses | 2 |
significant | graft | 2 |
severe | patients | 2 |
severe | group | 2 |
severe | diseases | 2 |
respiratory | therapy | 2 |
human | recipients | 2 |
such | treatment | 2 |
higher | treatment | 2 |
different | risks | 2 |
different | response | 2 |
different | infections | 2 |
different | cmv | 2 |
common | treatment | 2 |
common | graft | 2 |
clinical | transplantation | 2 |
clinical | infections | 2 |
chronic | treatment | 2 |
chronic | transplant | 2 |
chronic | cmv | 2 |
anti | cmv | 2 |
acute | treatment | 2 |
acute | cell | 2 |
- | transplanting | 2 |
- | results | 2 |
- | diseases | 2 |
higher | transplant | 2 |
different | results | 2 |
- | case | 2 |
different | transplantation | 2 |
first | t | 2 |
different | transplants | 2 |
higher | risks | 2 |
higher | infection | 2 |
higher | disease | 2 |
high | transplantation | 2 |
hematopoietic | diseases | 2 |
first | treatment | 2 |
first | transplantation | 2 |
high | cells | 2 |
first | studies | 2 |
first | grafts | 2 |
first | cases | 2 |
early | response | 2 |
early | infections | 2 |
first | patients | 2 |
different | treatments | 2 |
earlier | time | 2 |
other | transplantations | 1 |
other | year | 1 |
other | virus | 1 |
other | responses | 1 |
other | transplantation | 1 |
other | time | 1 |
other | recipients | 1 |
others | result | 1 |
others | diseases | 1 |
positive | case | 1 |
others | therapies | 1 |
overall | cmv | 1 |
overall | day | 1 |
overall | group | 1 |
overall | hsct | 1 |
overall | infections | 1 |
overall | patient | 1 |
overall | t | 1 |
other | infection | 1 |
positive | graft | 1 |
positive | infection | 1 |
other | recipient | 1 |
negative | recipient | 1 |
other | hsct | 1 |
other | cmv | 1 |
lower | cell | 1 |
lower | cmv | 1 |
lower | graft | 1 |
lower | results | 1 |
positive | recipient | 1 |
median | graft | 1 |
median | risk | 1 |
median | t | 1 |
median | transplantation | 1 |
median | virus | 1 |
median | years | 1 |
negative | cases | 1 |
negative | disease | 1 |
negative | hsct | 1 |
negative | patient | 1 |
negative | responses | 1 |
negative | studies | 1 |
negative | therapy | 1 |
non | cmv | 1 |
non | response | 1 |
non | transplanted | 1 |
median | cells | 1 |
severe | therapy | 1 |
positive | responses | 1 |
positive | risk | 1 |
significant | time | 1 |
significant | virus | 1 |
significant | years | 1 |
specific | groups | 1 |
specific | infection | 1 |
specific | stem | 1 |
specific | time | 1 |
such | case | 1 |
such | disease | 1 |
such | donors | 1 |
such | grafts | 1 |
such | group | 1 |
such | patient | 1 |
such | recipient | 1 |
such | transplantation | 1 |
such | transplantations | 1 |
such | transplants | 1 |
such | treatments | 1 |
viral | cell | 1 |
viral | responses | 1 |
low | transplantation | 1 |
significant | risks | 1 |
significant | results | 1 |
significant | p | 1 |
renal | patients | 1 |
positive | treatment | 1 |
primary | patient | 1 |
primary | response | 1 |
primary | results | 1 |
primary | risk | 1 |
primary | transplant | 1 |
primary | transplants | 1 |
primary | virus | 1 |
renal | infection | 1 |
renal | response | 1 |
significant | group | 1 |
renal | t | 1 |
renal | therapy | 1 |
severe | case | 1 |
severe | response | 1 |
severe | studies | 1 |
severe | transplant | 1 |
severest | cases | 1 |
significant | cell | 1 |
significant | day | 1 |
lower | % | 1 |
early | treatments | 1 |
low | responses | 1 |
first | cells | 1 |
common | donors | 1 |
common | recipients | 1 |
common | risk | 1 |
common | stem | 1 |
common | treatments | 1 |
commonest | infections | 1 |
different | cells | 1 |
different | disease | 1 |
different | graft | 1 |
different | group | 1 |
different | patient | 1 |
different | study | 1 |
earlier | study | 1 |
earlier | therapies | 1 |
earlier | transplant | 1 |
earlier | transplantation | 1 |
earlier | years | 1 |
early | case | 1 |
early | months | 1 |
early | patient | 1 |
early | study | 1 |
common | donor | 1 |
clinical | treatment | 1 |
clinical | transplant | 1 |
- | treatments | 1 |
- | diseased | 1 |
- | grafts | 1 |
- | grouping | 1 |
- | months | 1 |
- | result | 1 |
- | resulted | 1 |
- | studied | 1 |
- | studies | 1 |
- | therapies | 1 |
acute | cmv | 1 |
clinical | therapy | 1 |
acute | patients | 1 |
acute | risk | 1 |
acute | t | 1 |
acute | virus | 1 |
anti | t | 1 |
anti | virus | 1 |
chronic | patients | 1 |
clinical | group | 1 |
clinical | groups | 1 |
early | times | 1 |
first | donor | 1 |
low | patients | 1 |
first | graft | 1 |
human | transplant | 1 |
human | viruses | 1 |
immune | donor | 1 |
immune | donors | 1 |
immune | responsing | 1 |
immune | studies | 1 |
immune | t | 1 |
long | disease | 1 |
long | p | 1 |
long | therapy | 1 |
long | treatment | 1 |
longer | cmv | 1 |
longer | disease | 1 |
longer | studies | 1 |
longer | therapy | 1 |
longest | disease | 1 |
longest | time | 1 |
low | cmv | 1 |
low | donor | 1 |
low | groups | 1 |
low | infection | 1 |
human | patient | 1 |
human | hsct | 1 |
human | group | 1 |
high | cell | 1 |
first | p | 1 |
first | recipient | 1 |
first | transplants | 1 |
first | virus | 1 |
hematopoietic | disease | 1 |
hematopoietic | donor | 1 |
hematopoietic | hsct | 1 |
hematopoietic | recipient | 1 |
hematopoietic | responses | 1 |
high | p | 1 |
human | donors | 1 |
high | risks | 1 |
high | transplanted | 1 |
high | virus | 1 |
higher | % | 1 |
higher | day | 1 |
higher | donor | 1 |
higher | recipient | 1 |
higher | transplantation | 1 |
highest | cmv | 1 |
viral | results | 1 |